Author | Reem Karmali, MD | OncLive

Author | Reem Karmali, MD

Articles

Dr. Karmali on the Impact of CAR T-Cell Therapy in DLBCL

December 14, 2017

Video

Reem Karmali, MD, Feinberg School of Medicine, Northwestern University, discusses the impact of chimeric antigen receptor (CAR) T-cell therapy on the treatment of patients with diffuse large B-cell lymphoma (DLBCL).

Dr. Karmali on the Future of CAR T-Cell Therapy in DLBCL

October 23, 2017

Video

Reem Karmali, MD, Feinberg School of Medicine, Northwestern University, discusses the future of chimeric antigen receptor (CAR) T-cell therapy in diffuse large B-cell lymphoma (DLBCL).

Dr. Karmali Discusses Toxicites Associated With CAR T-Cell Therapies

October 20, 2017

Video

Reem Karmali, MD, assistant professor of medicine (hematology and oncology), Feinberg School of Medicine, Northwestern University, discusses the toxicities associated with the use of chimeric antigen receptor (CAR) T-cell therapies.

Dr. Karmali on FDA Approval of KTE-C19 in Non-Hodgkin Lymphoma

October 19, 2017

Video

Reem Karmali, MD, assistant professor of medicine (hematology and oncology), Feinberg School of Medicine, Northwestern University, discusses the FDA approval of axicabtagene ciloleucel (KTE-C19; axi-cel) for the treatment of patients with non-Hodgkin lymphoma.

x